The transcription factor Kruppel-like factor 5 promotes cell growth and metastasis via activating PI3K/AKT/Snail signaling in hepatocellular carcinoma

被引:25
|
作者
An, Tingting [1 ]
Dong, Tianxiu [1 ]
Zhou, Haoxin [2 ]
Chen, Yaodong [1 ]
Zhang, Jiuwei [1 ]
Zhang, Yu [1 ]
Li, Zizhuo [1 ]
Yang, Xiuhua [1 ]
机构
[1] Harbin Med Univ, Affiliated Hosp 1, Dept Abdominal Ultrasound, 23 Youzheng St, Harbin 150001, Heilongjiang, Peoples R China
[2] Harbin Med Univ, Affiliated Hosp 1, Dept Emergency Surg, Harbin 150001, Heilongjiang, Peoples R China
关键词
Kruppel-like factor 5; Hepatocellular carcinoma; Proliferation; Migration; EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-METASTASIS; CANCER CELLS; KLF5; APOPTOSIS; PATHWAY; PROLIFERATION; INVASION;
D O I
10.1016/j.bbrc.2018.11.084
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The transcription factor Kruppel-like factor 5 (KLF5) is highly expressed in many cancers and serves as a prognostic factor. However, the function of KLF5 in hepatocellular carcinoma (HCC) is unclear. In this study, we found that KLF5 was significantly overexpressed in HCC cell lines and specimens, and high KLF5 expression predicted a poor prognosis for HCC patients. Then, we studied the effects of KLF5 on the proliferation, apoptosis, migration and invasion of HCC cells in vitro and vivo. The inhibition of KLF5 markedly inhibited HCC growth and metastasis, while KLF5 overexpression promoted these processes. In addition, we observed that KLF5 could promote the epithelial-mesenchymal transition (EMT) in HCC via the PI3K/AKT/Snail signaling pathway. The silencing of KLF5 in HCC cell lines downregulated the expression of N-cadherin, Vimentin and Snail and increased the expression of the epithelial marker E-cadherin. The expression of MMP2 and MMP9 was also decreased in KLF5-silenced HCC cells. However, opposite results were observed in the KLF5-overexpressing group. These results indicate that KLF5 plays a significant role in HCC progression and metastasis and induces EMT via activating PI3K/AKT/Snail signaling, and the inhibition of KLF5 may be a potential treatment modality for patients with HCC. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码:159 / 168
页数:10
相关论文
共 50 条
  • [21] PODXL promotes malignant progression of hepatocellular carcinoma by activating PI3K/AKT pathway
    Ding, Yifeng
    Wang, Xiaoqing
    Shu, Fei
    Pan, Kehua
    Chen, Xiaohong
    Liu, Qingquan
    JOURNAL OF MOLECULAR HISTOLOGY, 2024, 55 (06) : 1107 - 1120
  • [22] Acylglycerol kinase promotes tumour growth and metastasis via activating the PI3K/AKT/GSK3β signalling pathway in renal cell carcinoma
    Zhu, Qian
    Zhong, Ai-Lin
    Hu, Hao
    Zhao, Jing-Jing
    Weng, De-Sheng
    Tang, Yan
    Pan, Qiu-Zhong
    Zhou, Zi-Qi
    Song, Meng-Jia
    Yang, Jie-Ying
    He, Jun-Yi
    Liu, Yuan
    Li, Min
    Hu, Wan-Ming
    Yang, Chao-Pin
    Xiang, Tong
    Chen, Ming-Yuan
    Ma, Gang
    Guo, Ling
    Xia, Jian-Chuan
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [23] Acylglycerol kinase promotes tumour growth and metastasis via activating the PI3K/AKT/GSK3β signalling pathway in renal cell carcinoma
    Qian Zhu
    Ai-Lin Zhong
    Hao Hu
    Jing-Jing Zhao
    De-Sheng Weng
    Yan Tang
    Qiu-Zhong Pan
    Zi-Qi Zhou
    Meng-Jia Song
    Jie-Ying Yang
    Jun-Yi He
    Yuan Liu
    Min Li
    Wan-Ming Hu
    Chao-Pin Yang
    Tong Xiang
    Ming-Yuan Chen
    Gang Ma
    Ling Guo
    Jian-Chuan Xia
    Journal of Hematology & Oncology, 13
  • [24] Kruppel-like Factor 6 Suppresses the Progression of Pancreatic Cancer by Upregulating Activating Transcription Factor 3
    Xiong, Qunli
    Zhang, Zhiwei
    Yang, Yang
    Xu, Yongfeng
    Zhou, Ying
    Zhang, Su
    Liu, Jinlu
    Zheng, Ying
    Zhu, Qing
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (01)
  • [25] Notch1 activation promotes renal cell carcinoma growth via PI3K/Akt signaling
    Xu, Le
    Zhu, Yu
    Xu, Jiejie
    Wu, Kerong
    Li, Jinfeng
    Xu, Wenping
    Liu, Haiou
    Wang, Shanshan
    Yin, Hankun
    Chen, Lin
    Wang, Guomin
    Lin, Zongming
    CANCER SCIENCE, 2012, 103 (07) : 1253 - 1258
  • [26] Eukaryotic elongation factor 2 kinase promotes angiogenesis in hepatocellular carcinoma via PI3K/Akt and STAT3
    Zhou, Ying
    Li, Yaoting
    Xu, Shihao
    Lu, Jing
    Zhu, Ziyi
    Chen, Shaoli
    Tan, Yuan
    He, Peng
    Xu, Jin
    Proud, Christopher G.
    Xie, Jianling
    Shen, Kaikai
    INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (05) : 1383 - 1395
  • [27] STC2 promotes head and neck squamous cell carcinoma metastasis through modulating the PI3K/AKT/Snail signaling
    Yang, Shuwen
    Ji, Qinghai
    Chang, Bin
    Wang, Yan
    Zhu, Yongxue
    Li, Duanshu
    Huang, Caiping
    Wang, Yulong
    Sun, Guohua
    Zhang, Ling
    Guan, Qing
    Xiang, Jun
    Wei, Wenjun
    Lu, Zhongwu
    Liao, Tian
    Meng, Jiao
    Wang, Ziliang
    Ma, Ben
    Zhou, Li
    Wang, Yu
    Yang, Gong
    ONCOTARGET, 2017, 8 (04) : 5976 - 5991
  • [28] Sortilin 1 regulates hepatocellular carcinoma progression by activating the PI3K/AKT signaling
    Ye, S.
    Wang, B.
    Zhou, Y.
    Sun, Q.
    Yang, X.
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2022, 41
  • [29] Kruppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of broblast growth factor binding protein 1
    Zheng, H-Q
    Zhou, Z.
    Huang, J.
    Chaudhury, L.
    Dong, J-T
    Chen, C.
    ONCOGENE, 2009, 28 (42) : 3702 - 3713
  • [30] miR-3691-5p promotes hepatocellular carcinoma cell migration and invasion through activating PI3K/Akt signaling by targeting PTEN
    Du, Wei
    Zhang, Xu
    Wan, Zhen
    ONCOTARGETS AND THERAPY, 2019, 12 : 4897 - 4905